InCapta Inc (OTCMKTS:INCT) and xTV recently got together to create mobile apps based on the latter’s CloudTV Content Delivery Network. It is expected that InCapta’s initial product based on the CloudTV platform will be a music app.
The music app will be geared to independent artists and their fans. Future apps that InCapta Inc (OTCMKTS:INCT) will base on xTV’sCloudTV platform will include celebrity mobile games and a host of other media apps such as for talk shows, news and others.
According to InCapta’s CEO, John Fleming, using xTV’s platform will enable them to create and deploy branded apps quickly and easily.
InCapta Inc (OTCMKTS:INCT) now becomes one of the third-party developers that are basing their next-generation apps on xTV platform.
Eclipse Resources Corp (NYSE:ECR) gets wings to fly after positive mention by RBC Capital
Eclipse Resources Corp (NYSE:ECR)’s shares rose more than 29.3% in the last session following a positive comment by RBC Capital. The equity research firm reiterated its Outperform rating on Eclipse, the surprise move came at a time when oil companies are going through a difficult time owing to collapse in crude prices.
On top of the positive rating, RBC Capital also has a lofty price target of $2.50 on the stock.
A number of hedge funds have also recently disclosed either buying to boosting their stakes in Eclipse Resources Corp (NYSE:ECR). Those bullish investors include Advisory Research Inc, Columbia Pacific Advisors LLC and Ameriprise Financial Inc.
The reiteration of Outperform rating on Eclipse Resources Corp (NYSE:ECR) will not only serve to boost investor confidence on the stock, but also scare away short-sellers.
Oncothyreon Inc (USA) (NASDAQ:ONTY) guides cash expenditure of up to $40 million
Oncothyreon Inc (USA) (NASDAQ:ONTY) recently provided financial guidance for 2016. The management expects expenditures for 2016 to rise above the levels seen in 2015. That is because Phase 2 trial of ONT-380 is expected to consume more money this year. As such, cash expenditure in 2016 is projected to be in the band of $38 to $40 million.
Given that Oncothyreon Inc (USA) (NASDAQ:ONTY) finished 2015 with cash and others short-time investments of $56.4 million, the management doesn’t foresee any cash shortfall. As such, existing resources are expected to be enough to fund operations over the next 12 months or more.